(Q48845481)

16 February 2018

title

Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography. (English)

1 reference

16 February 2018

1 reference

Nagasawa H

1

1 reference

16 February 2018

Tanji H

2

1 reference

16 February 2018

Itoyama Y

3

1 reference

16 February 2018

Saito H

4

1 reference

16 February 2018

Kimura I

5

1 reference

16 February 2018

Fujiwara T

6

1 reference

16 February 2018

Iwata R

7

1 reference

16 February 2018

Itoh M

8

1 reference

16 February 2018

Ido T

9

1 reference

16 February 2018

publication date

1 December 1996

1 reference

16 February 2018

Journal of the Neurological Sciences

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 February 2018

volume

144

1 reference

16 February 2018

issue

1-2

1 reference

16 February 2018

page(s)

70-76

1 reference

16 February 2018

describes a project that uses

positron emission tomography

1 reference

based on heuristic

inferred from title

cites work

[11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Evidence for plasticity of the dopaminergic system in parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Cerebral metabolism of 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Dopamine visualized in the basal ganglia of living man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

A comparison of clinical and pathological features of young- and old-onset Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Young-onset Parkinson's disease: a clinical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Parkinsonism: onset, progression, and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Striatal dopamine distribution in parkinsonian patients during life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Young onset Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2900168-2

10.1016/S0022-510X(96)00168-2

7 January 2021

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018